HomeHealthcare & Life SciencesPharmaceuticals Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market

South East Asia Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market Size & Outlook, 2026-2034


South East Asia Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market Insights

  • Based on Reed Intelligence findings, the South East Asia Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market reached USD 6.78 Million in 2025 and is estimated to attain USD 14.58 Million by 2034.
  • From 2026 to 2034, the South East Asia market is expected to grow at a steady CAGR of 8.91%.
  • Within the Treatment Type category, Drug Therapy dominated in 2025 in terms of market size contribution.
  • Over the forecast period, Supportive Therapy is forecasted to deliver the fastest growth, positioning it as the most lucrative Treatment Type segment.

Other Key Findings


  • South East Asia contributed 3.66% to the global Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market size in 2025.
  • By 2034, United States is forecasted to remain the largest global market for Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market.
  • In Asia Pacific, China is projected to capture the leading share of market size by 2034.
  • Among Asia Pacific markets, Taiwan is expected to post the fastest growth, reaching USD 8.12 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 6.78 Million
Market Size In 2034 USD 14.58 Million
Largest segment Drug Therapy
Units Revenue in USD Million
CAGR 8.91% (2026-2034)
Segmnetation Covered
Treatment Type
  1. Drug Therapy
  2. Gene Therapy
  3. Supportive Therapy
Route of Administration
  1. Oral
  2. Injectable
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Homecare Settings
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports